BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 12700661)

  • 1. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
    Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW
    Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
    Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
    Buhl AM; Cambier JC
    J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylinositol 3-kinase-dependent mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 and NF-kappa B signaling pathways are required for B cell antigen receptor-mediated cyclin D2 induction in mature B cells.
    Piatelli MJ; Wardle C; Blois J; Doughty C; Schram BR; Rothstein TL; Chiles TC
    J Immunol; 2004 Mar; 172(5):2753-62. PubMed ID: 14978074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol 3-kinase is required for the transcriptional activation of cyclin D2 in BCR activated primary mouse B lymphocytes.
    Glassford J; Vigorito E; Soeiro I; Madureira PA; Zoumpoulidou G; Brosens JJ; Turner M; Lam EW
    Eur J Immunol; 2005 Sep; 35(9):2748-61. PubMed ID: 16114097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes.
    Tan JE; Wong SC; Gan SK; Xu S; Lam KP
    J Biol Chem; 2001 Jun; 276(23):20055-63. PubMed ID: 11274146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible signal transduction pathway for cyclin D2 expression by a pectic polysaccharide from the roots of bupleurum falcatum L. in murine B cell.
    Matsumoto T; Hosono-Nishiyama K; Guo YJ; Ikejima T; Yamada H
    Int Immunopharmacol; 2005 Aug; 5(9):1373-86. PubMed ID: 15953564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase.
    Khan WN
    Immunol Res; 2001; 23(2-3):147-56. PubMed ID: 11444380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation.
    Fluckiger AC; Li Z; Kato RM; Wahl MI; Ochs HD; Longnecker R; Kinet JP; Witte ON; Scharenberg AM; Rawlings DJ
    EMBO J; 1998 Apr; 17(7):1973-85. PubMed ID: 9524120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes.
    Piatelli MJ; Doughty C; Chiles TC
    J Biol Chem; 2002 Apr; 277(14):12144-50. PubMed ID: 11823472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction.
    Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF
    J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD38 signaling regulates B lymphocyte activation via a phospholipase C (PLC)-gamma 2-independent, protein kinase C, phosphatidylcholine-PLC, and phospholipase D-dependent signaling cascade.
    Moreno-García ME; López-Bojórques LN; Zentella A; Humphries LA; Rawlings DJ; Santos-Argumedo L
    J Immunol; 2005 Mar; 174(5):2687-95. PubMed ID: 15728476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell receptor directs the activation of NFAT and NF-kappaB via distinct molecular mechanisms.
    Antony P; Petro JB; Carlesso G; Shinners NP; Lowe J; Khan WN
    Exp Cell Res; 2003 Nov; 291(1):11-24. PubMed ID: 14597404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes.
    Tanguay DA; Chiles TC
    J Immunol; 1996 Jan; 156(2):539-48. PubMed ID: 8543804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction.
    Suzuki H; Matsuda S; Terauchi Y; Fujiwara M; Ohteki T; Asano T; Behrens TW; Kouro T; Takatsu K; Kadowaki T; Koyasu S
    Nat Immunol; 2003 Mar; 4(3):280-6. PubMed ID: 12563258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells.
    Yasuda T; Tezuka T; Maeda A; Inazu T; Yamanashi Y; Gu H; Kurosaki T; Yamamoto T
    J Exp Med; 2002 Jul; 196(1):51-63. PubMed ID: 12093870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Btk and phospholipase C gamma 2 can function independently during B cell development.
    Halcomb KE; Contreras CM; Hinman RM; Coursey TG; Wright HL; Satterthwaite AB
    Eur J Immunol; 2007 Apr; 37(4):1033-42. PubMed ID: 17372989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
    Mizuno T; Rothstein TL
    J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bruton's tyrosine-kinase-deficient murine B lymphocytes fail to enter S phase when stimulated with anti-immunoglobulin plus interleukin-4.
    Forssell J; Nilsson A; Sideras P
    Scand J Immunol; 1999 Feb; 49(2):155-61. PubMed ID: 10075019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKCbeta modulates antigen receptor signaling via regulation of Btk membrane localization.
    Kang SW; Wahl MI; Chu J; Kitaura J; Kawakami Y; Kato RM; Tabuchi R; Tarakhovsky A; Kawakami T; Turck CW; Witte ON; Rawlings DJ
    EMBO J; 2001 Oct; 20(20):5692-702. PubMed ID: 11598012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.